CA9 and hepatocellular carcinoma: Cho et al. (Cho et al., 2019) demonstrated that CA IX has overexpressed in HCC and CA IX inhibitor (acetazolamide) significantly suppressed the growth of HCC xenograft tumors in nude mice.